- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01444066
The Role Of Empiric Dilation In Patients With Dysphagia With Normal Endoscopy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Dysphagia typically refers to the sensation of food being stuck in the throat or chest( esophageal dysphagia) as well as difficulty with the initiation of swallowing (oropharyngeal dysphagia). It is typically classified into oropharyngeal and esophageal dysphagia. Oropharyngeal dysphagia is typically the result of neuromuscular disease as well as head and neck malignancy and can be diagnosed on the basis of history and physical examination in most cases. Patients with esophageal dysphagia can further be sub-classified into two groups; those with obvious abnormality in the esophageal mucosa or motility on endoscopy and those with normal findings on endoscopic examination.
The diagnosis and treatment of patients with dysphagia and abnormal findings on endoscopy has been extensively studied and there are well-define practice guidelines availed on the subject. In contrast to this the management strategy for the group of patients with esophageal type dysphagia and a normal appearing esophagus on upper endoscopy (DNE) has been a topic of controversy for over a decade. Those patients with DNE are thought to fall into several categories, those with very subtle strictures and rings in the esophagus that are not seen during endoscopy, as well as patients with non-erosive reflux disease, eosinophilic esophagitis, primary motility disorders of the esophagus, and finally those with "functional" dysphagia (in whom no cause can be identified). Several approaches have been advocated for the evaluation and treatment of patients with DNE, including a trial of proton pump inhibitor therapy, obtaining random biopsies to exclude eosinophilic esophagitis and non-erosive reflux disease, referral for manometry and esophageal pH monitoring, as well as empiric esophageal dilation with a large caliber bougie. Of these options empiric esophageal dilation with a large diameter bougie has been the initial management approach recommended by the most recent AGA guidelines as well as many experts in the field of esophagology, for the treatment of DNE.
The initial evidence for empiric esophageal dilation in patients with DNE came from a retrospective study by Marshal et al, who found that 50% of patients experienced a sustained improvement in symptoms following dilation with a large diameter bougie. This was followed by a randomized controlled trial by Colon and coworkers, who again found a significant benefit to empiric esophageal bougie dilation. However, two randomized trials in the mid-2000's did not find any benefit to empiric esophageal dilation; although the dilation methods used in these studies differed from that used by Marshal and Colon et al. Despite these conflicting results empiric dilation continues to be popular by community gastroenterologists, and is perceived to be safe effective intervention for treating patients with DEN. A recent study by Olson et al found that empiric dilation for DNE was performed more commonly then dilation for dilation for esophageal strictures in the United States and is associated with a 0.65% complication rate. Additionally, in the current era of financial pressure on the medical community empiric dilation for DNE at the time of the first diagnostic upper endoscopy could lead to a significant savings if it is effective in relieving symptoms; by obviating the need for further diagnostic testing, medications and repeat endoscopy.
With this in mind, our goal is to conduct a randomized controlled trial evaluating the role of empiric dilation in patients with DNE, to help fill existing gaps in the medical literature. Specifically, prior studies are lacking with regard to three important points. First, esophageal manometry and pH monitoring were not uniformly performed on patients; this testing is crucial to excluding esophageal motility disorders and non-erosive reflux disease, which are thought to be causes of DNE. Second, esophageal biopsies were not performed in any of the studies; this has become a standard part of the evaluation of all patients with DNE over the past 5 years, as eosinophilic esophagitis and non-erosive reflux disease can lead to dysphagia and may be missed without microscopic examination of the esophageal mucosa. Finally, none of the studies used a standardized and validated dysphagia questionnaire, such as the Mayo Dysphagia Questionnaire (MDQ) to evaluate symptoms.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63112
- Washington University
-
Saint Louis, Missouri, United States, 63112
- Barnes Jewish Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients age: > 18 years.
- Outpatients undergoing EGD for dysphagia.
- Ability to provide written informed consent.
Exclusion Criteria:
- Abnormal endoscopy (stricture, abnormal motility or mucosa observed)
- Oropharyngeal dysphagia suspected based on history and physical examination
- History of CVA or other neurologic disorder
- Known connective tissue disease (SLE, scleroderma, CREST, RA)
- Known histopathology based esophageal motor disorder, e.g. achalasia
- Prior thoracic or foregut surgery (excluding cholecystectomy)
- Prior thoracic radiation therapy
- Hiatus hernia >2 cm as judged during EGD
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: dilation to 27 French
|
Esophagus will be dilated with a Savory dilator.
|
Experimental: Dilation of the esophagus to 54 French
Esophagus will be dilated with a Savory dilator
|
Esophagus will be dilated with a Savory dilator.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Improvement in dysphagia, quantified using 10 cm VAS scale
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Evaluate the yield of esophageal biopsy in patients with dysphagia with normal endoscopy
Time Frame: 12 months
|
12 months
|
Evaluate the yield of HRM and pH monitoring in patients with dysphagia and normal endoscopy
Time Frame: 12 months
|
12 months
|
Identify predictors of response to empiric dilation in patients with dysphagia and normal endoscopy
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201106053
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dysphagia With Normal Endoscopy
-
Centre Hospitalier Universitaire DijonTerminatedPatient With Bronchial EndoscopyFrance
-
Topcon Medical Systems, Inc.CompletedSubjects Presenting With Normal or With Ocular PathologyUnited States
-
Meir Medical CenterUnknownPatients With Normal ECG | Patients With Pathological ECGIsrael
-
Topcon Medical Systems, Inc.CompletedSubjects Presenting With Normal EyesUnited States
-
Englewood Hospital and Medical CenterWithdrawnInpatients With Normal Neurological FunctionUnited States
-
Massachusetts Eye and Ear InfirmaryCompletedNormal Individuals With Visual AberrationsUnited States
-
University Hospital, BrestCompletedPatents With Normal VQ/SPECTFrance
-
Peking University People's HospitalCompletedGastrointestinal Endoscopy | Elderly Patients | Remimazolam Besylate | Etomidate Combined With PropofolChina
-
Sohag UniversityCompletedAll Patients With Upper GIT Symptoms and Underwent Upper EndoscopyEgypt
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedPeople With Normal Sense of SmellNorway
Clinical Trials on Dilation of the esophagus
-
Vastra Gotaland RegionSahlgrenska University Hospital, Sweden; The Göteborg Medical Society, SwedenCompletedGastric Cancer | Cancer of EsophagusSweden
-
University of PittsburghNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedEustachian Tube DysfunctionUnited States
-
Virginia Commonwealth UniversityUS Endoscopy Group Inc.Recruiting
-
Piedmont Ear, Nose, Throat and Related Allergy, PCAcclarentUnknownChronic Eustachian Salpingitis
-
Sunnybrook Health Sciences CentreTerminated
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; Johns Hopkins University; University... and other collaboratorsCompletedIdiopathic Subglottic Stenosis (iSGS)United States, Australia, Iceland, United Kingdom
-
Cliniques universitaires Saint-Luc- Université...UnknownFemoropopliteal Arterial StenosisBelgium
-
Mayo ClinicCompletedAchalasiaUnited States
-
Nantes University HospitalCompleted